TLP
Tri Locum Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.2M | Buy |
+89,525
| New | +$29.2M | 8.86% | 3 |
|
|
2024
Q3 | – | Sell |
-45,000
| Closed | -$10.9M | – | 21 |
|
|
2024
Q2 | $10.9M | Buy |
+45,000
| New | +$10.9M | 2.76% | 16 |
|
|
2023
Q3 | – | Sell |
-29,506
| Closed | -$5.6M | – | 62 |
|
|
2023
Q2 | $5.6M | Buy |
+29,506
| New | +$5.6M | 2.08% | 22 |
|